Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis Optica.
Interleukin-17 in human inflammatory diseases.
Delayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nerves.
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Phase imaging in brain using SWIFT.
[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy].
Ozanimod: a better or just another S1P receptor modulator?
The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
[Quality of life in multiple sclerosis--association with clinical features, fatigue and depressive syndrome].
Roles for HB-EGF and CD9 in multiple sclerosis.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
[Natalizumab as induction therapy in multiple sclerosis.]
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic.
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
Interferon Beta and Long-term Disability in Multiple Sclerosis.
Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork.
Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study.
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry.
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
Pages
« first
‹ previous
…
485
486
487
488
489
490
491
492
493
…
next ›
last »